RESMED INC — Director's Dealing 2010

Aug 20, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-08-18

Reporting Person: FARRELL PETER C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-08-18	ResMed Common Stock	M	75000	$25.275	Acquired	604374	Direct
2010-08-18	ResMed Common Stock	S	75000	$63.9243	Disposed	229374	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-18	ResMed Common Stock Options	$25.275	M	75000	Disposed	2011-07-02	ResMed Common Stock (75000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	100000	Indirect
ResMed Common Stock	100000	Indirect
ResMed Common Stock	100000	Indirect

Footnotes

F1: Represents date options first became exercisable.

F2: This transaction was executed in multiple trades at prices ranging from $63.49 to $64.48. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.